SCHEMBL1651397

SCHEMBL1651397

COc1cc(O)cc(C=Cc2cc3ccccc3s2)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TUBB4A P04350 4/20 0.64
▸ TUBB P07437 4/20 0.64
▸ TUBA3C P0DPH7 4/20 0.64
▸ TUBA1B P68363 4/20 0.64
▸ TUBA4A P68366 4/20 0.64
▸ TUBB4B P68371 4/20 0.64
▸ TUBB3 Q13509 4/20 0.64
▸ TUBB2A Q13885 4/20 0.64
▸ TUBB8 Q3ZCM7 4/20 0.64
▸ TUBA3E Q6PEY2 4/20 0.64
▸ TUBA1A Q71U36 4/20 0.64
▸ TUBA1C Q9BQE3 4/20 0.64
▸ TUBB6 Q9BUF5 4/20 0.64
▸ TUBB2B Q9BVA1 4/20 0.64
▸ TUBB1 Q9H4B7 4/20 0.64
▸ KDM4E B2RXH2 3/20 0.60
▸ MEN1 O00255 2/20 0.60
▸ MAPT P10636 2/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ USP2 O75604 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1651393 1.00 TUBB4A (0.64) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL1650720 0.99 TUBB4A (0.62) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL1650722 0.99 TUBB4A (0.62) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL12780792 0.92 TUBB4A (0.70) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL12729860 0.86 TUBB4A (0.64) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL12729863 0.84 TUBB4A (0.57) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL12729865 0.83 TUBB4A (0.63) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL19076204 0.83 TUBB4A (0.66) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL12729780 0.82 KDM4E (0.54) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL21654882 0.81 CYP2A6 (0.57) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8530512-B2 Broad spectrum gram-positive antimicrobials and anthelmintics with efficacy against drug-resistant strains and Mycobacterium species MONTE AARON P (US) 2013-09-10 — — US claimed
US-20110092578-A1 Broad Spectrum Gram-Positive Antimicrobials and Anthelmintics with Efficacy Against Drug-Resistant Strains and Mycobacterium Species MONTE AARON P 2011-04-21 — — US claimed
US-10550095-B2 Cancerous cell growth inhibiting compounds WISYS TECHNOLOGY FOUNDATION, INC. (US) 2020-02-04 — — US disclosed
US-8530512-B2 Broad spectrum gram-positive antimicrobials and anthelmintics with efficacy against drug-resistant strains and Mycobacterium species MONTE AARON P (US) 2013-09-10 — — US disclosed
US-20110092578-A1 Broad Spectrum Gram-Positive Antimicrobials and Anthelmintics with Efficacy Against Drug-Resistant Strains and Mycobacterium Species MONTE AARON P 2011-04-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10550095-B2 Cancerous cell growth inhibiting compounds TYR, MKI67, MC1R TUBB4A 1471/4885TUBB 1915/4885TUBA3C 3673/4885
US-20110092578-A1 Broad Spectrum Gram-Positive Antimicrobials and Anthelmintics with Efficacy Against Drug-Resistant Strains and Mycobacterium Species ABCC1, H1-3, H1-2 TUBB4A 1871/4885TUBB 509/4885TUBA3C 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback